Because some of the autoreactive T-cell clones specific for human PDC-E2 cross-react to mimicry peptides having an EIExDK motif derived from nuclear antigens such as human gp210 and sp100, we studied the clinical significance of antinuclear antibodies (ANA) in primary biliary cirrhosis (PBC) patients registered to the National Hospital Organization Study Group for Liver Disease in Japan (NHOSLJ). We found that there are two different types of progression in PBC; one is a hepatic failure-type progression which is represented by positive anti-gp210 antibodies and the other is a portalhypertension-type progression which is represented by positive anticentromere antibodies. We discuss the predictive role of these ANA in the long-term outcome of PBC and the mechanisms by which two different PBC progression types occur based on molecular mimicry and aberrant expression of nuclear antigens.
Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Publishing Authors By Initials
Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Hepatology research : the official journal of the
VOLUME: 37 Suppl 3
Page Numbers: S412-9
Journal Abbreviation: Hepatol. Res.
ISSN: 1386-6346
DAY: 12
MONTH: Oct
YEAR: 2007
Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9711801
Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis.
AFFILIATION: National Hospital Organization (NHO) Nagasaki Medical Center, Omura; Nagasaki University Graduate School of Biomedical Sciences, Nagasaki; and National Hospital Organization Study Group for Liver Disease in Japan (NHOSLJ), Fukuoka, Japan.
Country: Netherlands
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Hepatol Res
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis Related Publications